Keating Financial Advisory Services, Inc.
Position in GH — Guardant Health, Inc.
CIK 2103443
MANHATTAN, KS
Position in GH
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$22,804
+$10,242 QoQ
Shares Held
152
+11.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#499
of 593 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Keating Financial Advisory Services, Inc. holds $1,217,060 across 26 Diagnostics & Research names. GH ranks #11 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
475 | $238,146 | |
| 2 | DGX |
Quest Diagnostics Inc
|
772 | $163,625 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
308 | $162,143 | |
| 4 | WAT |
Waters Corp /De/
|
397 | $148,890 | |
| 5 | DHR |
Danaher Corp /De/
|
695 | $132,383 | |
| 6 | MTD |
Mettler Toledo International Inc/
|
66 | $84,315 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
305 | $58,932 | |
| 8 | NTRA |
Natera, Inc.
|
213 | $57,818 |
All Filings in GH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,804 | 152 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $12,562 | 136 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,810 | 145 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||